SCHEMBL7832092

SCHEMBL7832092

Cc1cccc(CC(NCC(=O)Oc2ccccc2)C(=O)OC(C)(C)C)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGA4 P13612 2/20 0.41
ITGB7 P26010 2/20 0.41
MEN1 O00255 1/20 0.40
OPRM1 P35372 1/20 0.40
OPRD1 P41143 1/20 0.40
KMT2A Q03164 1/20 0.40
MAOA P21397 1/20 0.37
MAPT P10636 5/20 0.37
TDP1 Q9NUW8 3/20 0.37
POLB P06746 1/20 0.36
NTSR1 P30989 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
CYP3A4 P08684 1/20 0.35
CYP2C8 P10632 1/20 0.35
CYP2C9 P11712 1/20 0.35
NPR3 P17342 1/20 0.35
CYP2C19 P33261 1/20 0.35
MLYCD O95822 1/20 0.35
PPARG P37231 1/20 0.35
SIRT2 Q8IXJ6 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6779226 0.76 KMT2A (0.34) MEN1OPRM1OPRD1KMT2AMAPT
SCHEMBL7835232 0.72 KMT2A (0.41) MEN1OPRM1OPRD1KMT2AMAOA
SCHEMBL6428127 0.72 ITGA4 (0.62) ITGA4ITGB7MAPTTDP1POLB
SCHEMBL7428720 0.72 ITGA4 (0.59) ITGA4ITGB7MEN1KMT2AMAPT
SCHEMBL7428724 0.72 ITGA4 (0.59) ITGA4ITGB7MEN1KMT2AMAPT
SCHEMBL30191609 0.69 KMT2A (0.41) MEN1OPRM1OPRD1KMT2APOLB
SCHEMBL22035812 0.69 KMT2A (0.41) MEN1OPRM1OPRD1KMT2APOLB
SCHEMBL2374158 0.67 KMT2A (0.46) MEN1OPRM1OPRD1KMT2APOLB
SCHEMBL5849169 0.67 EPHX2 (0.50) MEN1KMT2AMAPT
SCHEMBL16798372 0.67 CPB2 (0.39) ITGA4ITGB7MAOAMAPTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0850221-B1 META-GUANIDINE, UREA, THIOUREA OR AZACYCLIC AMINO BENZOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS SEARLE & CO (US) 2001-07-18 EP disclosed
US-6028223-A AN INTEGRIN ANTAGONISTS TREATING BONE DISORDER, PERIODONTAL DISEASE, OSTEOPOROSIS, HUMORAL HYPERCALCEMIA OF MALIGNANCY, PAGET'S DISEASE, TUMOR ANGIOGENESIS, DIABETIC RETINOPATHY, ARTHRITIS, SMOOTH MUSCLE CELL MIGRATION AND RESTENOSIS G. D. SEARLE & CO. (US) 2000-02-22 US disclosed